Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s stock price rose 9.1% on Monday . The company traded as high as $0.46 and last traded at $0.17. Approximately 1,934 shares changed hands during trading, a decline of 90% from the average daily volume of 20,342 shares. The stock had previously closed at $0.15.
Cell MedX Trading Up 9.1 %
The firm has a 50-day moving average of $0.39 and a two-hundred day moving average of $0.21.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Recommended Stories
- Five stocks we like better than Cell MedX
- Stock Dividend Cuts Happen Are You Ready?
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- What is Put Option Volume?
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Election Stocks: How Elections Affect the Stock Market
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
